Dr. Halmos on the Emergence of KRAS-Targeted Therapies in Lung Cancer

Video

In Partnership With:

Balazs Halmos, MD, MS, discusses the emergence of KRAS-targeted therapies in lung cancer.

Balazs Halmos, MD, MS, director of the Multidisciplinary Thoracic Oncology Program and director of the Section of Thoracic Medical Oncology for Montefiore Health Systems, first director of Clinical Cancer Genetics and professor of clinical medicine at the Albert Einstein College of Medicine, discusses the emergence of KRAS-targeted therapies in lung cancer.

Targeting KRAS mutations in lung cancer is an unfolding story, says Halmos. Efficacy data with KRAS inhibitors as single agents and in combination regimens with conventional first- and second-line options, such as chemotherapy and immunotherapy, will likely emerge in 2021, Halmos explains.

Additionally, as KRAS mutations are present in a significant proportion of patients with lung cancer, the field is hoping to develop an understanding of which investigational KRAS-directed therapy yields the most significant efficacy and in which specific patient populations, concludes Halmos.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD
Samer A. Srour, MB ChB, MS